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A B S T R A C T
Bromodomains (BRDs) are small protein domains often present in large multidomain proteins involved in
transcriptional regulation in eukaryotic cells. They currently represent valuable targets for the development of
inhibitors of aberrant transcriptional processes in a variety of human diseases. Here we report urea-induced
equilibrium unfolding experiments monitored by circular dichroism (CD) and fluorescence on two structurally
similar BRDs: BRD2(2) and BRD4(1), showing that BRD4(1) is more stable than BRD2(2). Moreover, we report a
description of their kinetic folding mechanism, as obtained by careful analysis of stopped-flow and temperature-
jump data. The presence of a high energy intermediate for both proteins, suggested by the non-linear depen-
dence of the folding rate on denaturant concentration in the millisec time regime, has been experimentally
observed by temperature-jump experiments. Quantitative global analysis of all the rate constants obtained over a
wide range of urea concentrations, allowed us to propose a common, three-state, folding mechanism for these
two BRDs. Interestingly, the intermediate of BRD4(1) appears to be more stable and structurally native-like than
that populated by BRD2(2). Our results underscore the role played by structural topology and sequence in
determining and tuning the folding mechanism.
1. Introduction
Proteins involved in the regulation of histone post-translational
modifications, such as those involved in acetylation, phosphorylation or
methylation, play a pivotal role in the control of gene expression [1],
therefore acting as “proof-editors” of the genetic code. Proteins acting
on the histone acetylation processes can be grouped in at least three
different subsets, on the basis of their specific function: “writer” pro-
teins (as Histone AcetylTransferases, HATs) responsible for the addition
of acetyl groups to specific lysine residues, “eraser” proteins removing
specific acetyl groups (as Histone DeAcetylases, HDACs), and “reader”
proteins, endowed with the ability to recognize and bind to specific
histone acetylated lysines (AcK), such as the Bromodomains (BRDs)
[2,3].
BRDs are conserved structural motifs of about 100 amino acids that
are often present in large multidomain proteins involved in a variety of
cellular processes, such as chromatin remodeling, post-translational
modifications or transcriptional control [4]. Members of the BET
(Bromo-Extra-Terminal domain) family (comprising human BRD2,
BRD3, BRD4 and BRDT) display common modular architecture with
two highly conserved amino-terminal BRDs, and a less conserved C-
terminal recruitment domain. Mutations or chromosomal rearrange-
ments affecting BRDs have been linked to various human diseases in-
cluding cancer, and therefore BRDs are currently considered a pro-
mising target for the development of small-molecule inhibitors aiming
at interfering with aberrant transcriptional processes in such diseases
[5–7].
The structure of a variety of BRDs has been solved and shows a
conserved left-handed helical bundle composed by four α-helices
termed αZ, αA, αB and αC (from the N-terminal to the C-terminal helix)
connected by loop regions of variable length (ZA and BC loops) (Fig. 1).
From a structural point of view the BRDs therefore belong to the all-α
fold class. Structural analyses of acetylated peptide-BRD complexes
have shown that the AcK binding site is a hydrophobic cavity present on
top of the helical bundle whose surface is shaped mainly by the ZA and
BC loops. Not surprisingly, given the pivotal role played by BRDs in a
variety of patho-physiological processes, a growing number of studies
are currently focusing on their ligand binding affinity and specificity.
However, little is known about the dynamic properties of these domains
and, to our knowledge, no information is available about the mechan-
isms of folding of BRDs. This lack of information is somewhat surprising
as it is known that for many proteins a relationship exists between
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folding and ligand binding mechanisms, e.g. in the classical induced-fit
model, in the case of other small protein domains involved in mediating
protein-protein interactions [8] or in the case of intrinsically disordered
proteins [9,10]. Interestingly, in the case of BRD domains, a ligand-
induced conformational change has been proposed and discussed
[11,12]. In light of these considerations we believe that obtaining in-
formation about the folding mechanism of the BRD domains may pave
the way to a better understanding of their binding mechanism.
In this report we investigate the thermodynamic properties and the
folding mechanism of two BET bromodomains: the second BRD of BRD2
(hereafter, BRD2(2)) and the first BRD of BRD4 (hereafter, BRD4(1)) by
equilibrium spectroscopy and pre steady-state kinetic experiments. We
decided to focus on these two BET BRDs because i) they are re-
presentative of the first and second domains generally found in the BET
BRD family and ii) they represent ideal experimental system to in-
vestigate conservation (if any) of the folding mechanism among mem-
bers of a fold family. Indeed these two BET BRDs display a 56% se-
quence similarity and, as can be seen from Fig. 1, they are structurally
very similar (Cα root-mean square deviation (RMSD) is 1.2± 0.7 Å). It
should be recalled that the folding mechanism of other all-α proteins
has been studied in detail [13–16], leading to the hypothesis that for-
mation of a folding intermediate is tuned by the specific α-helical
propensities.
Quantitative analyses of stopped-flow (SF) mixing experiments and
ultra-rapid temperature-jump (T-jump) data, allowed us to show that
the folding mechanism of both BRDs are consistent with the presence of
a folding intermediate, transiently populated in the sub-milliseconds
time-regime. However, our results suggest that the two intermediate
species show dissimilar thermodynamic and structural properties,
highlighting different dynamic properties of these two BRDs.
2. Materials and methods
2.1. Protein expression and purification
BRD2(2) and BRD4(1) were expressed in E.coli and purified as
previously described [17] and briefly reported in the legend to Fig. S1.
[17]. Structural integrity of the purified proteins was checked by CD
spectra in the far- and near-UV region (Figs. S2 and S3, respectively).
2.2. Urea-induced equilibrium unfolding
All experiments were carried out at 20 °C in 20 mM Tris/HCl, pH
7.5, 0.2 M NaCl, 200 μM DTT. Intrinsic fluorescence emission mea-
surements were carried out with a LS50B spectrofluorimeter (Perkin-
Elmer) using a 1.0 cm path length quartz cuvette. Fluorescence emis-
sion spectra were recorded from 300 to 450 nm (1 nm sampling in-
terval), with the excitation wavelength set at 295 nm. Circular di-
chroism (CD) measurements were performed with a JASCO J-720
spectropolarimeter using a 0.2-cm cuvette. For urea-induced equili-
brium unfolding, proteins (final concentration ranging over 50.0−100
μg/mL) were incubated at 20 °C at increasing concentrations of urea
(0−9.5 M). When equilibrium was reached, intrinsic fluorescence
emission and far-UV CD spectra were recorded in parallel. To test the
reversibility of the unfolding, BRD2(2) and BRD4(1) were denatured in
7.9 M urea at protein concentration ranging over 0.5–1.0 mg/mL. After
10 min, refolding was started by 15-fold dilution of the unfolding
mixture into solutions of the same buffer used for unfolding containing
decreasing urea concentrations. The final protein concentration ranged
over 50.0−100 μg/mL. After 24 h, intrinsic fluorescence emission and
far-UV CD spectra were recorded at 20 °C. All equilibrium unfolding
experiments were performed in triplicate. The changes in intrinsic
fluorescence emission spectra at increasing urea concentrations were
quantified as the changes of the relative fluorescence intensity at 345
and at 350 nm for BRD2(2) and BRD4(1), respectively. The excitation
wavelength used was 295 nm.
Urea-induced equilibrium unfolding transitions monitored by far-
UV CD ellipticity and intrinsic fluorescence emission changes were
analysed by fitting baseline and transition region data to a two-state
linear extrapolation model [18] according to= + −∆G ∆G m RT K[Urea] ln ( )H Ounf unf2 (1)
where ΔGunf is the free energy change for unfolding for a given dena-
turant concentration, ΔGH2 ° the free energy change for unfolding in the
absence of denaturant and m a slope term which quantifies the change
in ΔGunf per unit concentration of denaturant, R the gas constant, T the
temperature and Kunf the equilibrium constant for unfolding. The model
expresses the signal as a function of denaturant concentration:
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where yi is the observed signal, yU and yN are the baseline intercepts for
unfolded and native protein, sU and sN are the baseline slopes for the
unfolded and native protein, [X]i the denaturant concentration after the
ith addition, ΔGH2O the extrapolated free energy of unfolding in the
absence of denaturant, m the slope in a ΔGunfolding versus [X] plot.
The denaturant concentration at the midpoint of the transition,
[Urea]0.5, according to Eq. (2), is calculated as:= ∆G m[Urea] /H O0.5 2 (3)
2.3. Kinetic experiments
Stopped-flow kinetic folding experiments were carried out on a SX-
17 stopped-flow instrument (Applied Photophysics, Leatherhead, UK)
in Tris/HCl 50 mM buffer pH 7.5, 0.2 M NaCl, 2 mM DTT, at 20 °C; the
excitation wavelength was 280 nm and the fluorescence emission was
measured using a 320 nm cut-off glass filter. In all experiments, re-
folding and unfolding were initiated by a 11-fold dilution of the de-
natured or the native protein with the appropriate buffer. Usually 4–6
individual traces were accumulated and averaged. Final protein con-
centration was typically 5 μM.
Fig. 1. Structural alignment of BRD2(2) (pdb id: 3oni), shown in red, and BRD4(1) (pdb
id: 3uvx), shown in blue. The Trp residues are shown in sticks representations. BRD2(2)
contains only one Trp (Trp370, structurally homologous to Trp81 of BRD4(1)); BRD4(1)
presents two additional Trp residues (Trp75 and Trp120). The alignment was generated
using PyMol (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC).
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Analysis was performed by non-linear least squares fitting of ex-
ponential phases using the fitting procedures provided in the Applied
Photophysics software.
The relaxation kinetics was measured by using a Hi-Tech PTJ-64
capacitor-discharge T-jump apparatus (Hi-Tech, Salisbury, UK).
Degassed and filtered samples were slowly pumped through the 0.5 ×
2 mm quartz flow cell before data acquisition. Temperature was rapidly
changed with a jump-size of 9 °C (from 11 °C to 20 °C). Usually 10–20
individual traces were accumulated and averaged. The excitation wa-
velength was 296 nm and the fluorescence emission was measured
using a 320 nm cut-off glass filter. Protein concentration was typically
20 μM. The buffer used was Tris/HCl 50 mM buffer pH 7.5, 0.2 M NaCl,
200 μM DTT.
Experimental kinetic data were modeled on the basis of a three-state
folding scheme, either with an on- or off-pathway intermediate, as-
suming that the logarithm of the microscopic rate constants linearly
depends on the denaturant concentration: ln kij = ln kij° + mij
(RT)−1[urea], where kij° and mij represent the elementary rate constant
in the absence of urea and the urea dependence of the rate constant
(kinetic m value), 205 [19, 20].
For the two step reaction, global analysis of the two apparent rate
constants λ1 and λ2 was performed by non-linear least-squares fitting of
the kinetic data as previously described [19] using Graphpad Prism
5.04.
Kinetic ΔG values were calculated as follows: ΔGDN = - RT ln (kDI x
kIN) / (kID x kNI); ΔGDI = - RT ln kDI / kID. Tanford β-values (βT) were
calculated as follows: βT(D) = 0; βT(TS1) = - mDI /mDN; βT(I) = (mID -
mDI)/mDN; βT(TS2) = 1 – mNI/mDN; βT(N) = 1; mDN is the kinetically
derived ‘equilibrium’ m value, mDN =mID – mDI + mNI - mIN.
3. Results and discussion
3.1. Urea-induced equilibrium unfolding
The thermodynamic stability of BRD2(2) and BRD4(1) was de-
termined at pH 7.5 and 20 °C by urea-induced equilibrium unfolding
experiments, monitoring both the change of ellipticity at 222 nm by CD
spectroscopy (Fig. 2A) and the change of intrinsic fluorescence emission
(Fig. 2B). In all cases, the observed unfolding transitions were checked
for reversibility. The same samples used to monitor the far-UV CD
changes during the unfolding transition were used to monitor fluores-
cence emission changes, to allow a direct comparison of the data.
For both proteins, the denaturation curves obtained by monitoring
the CD signal at 222 nm are satisfactorily fitted to a two-state model.
The calculated unfolding free energy in water (ΔGH2O) for BRD2(2) is
8.83±0.59 kcal mol−1 and the m value is
1.93±0.13 kcal mol−1 M−1, while for BRD4(1) the same thermo-
dynamic parameters are ΔGH2O = 11.52±0.65 kcal mol−1 and m =
1.67±0.09 kcal mol−1 M−1, highlighting a larger stability for
BRD4(1) compared to BRD2(2) (ΔΔG = 2.69 kcal mol−1) (Table 1).
In the case of BRD2(2), fitting the unfolding transition obtained by
monitoring the changes of the fluorescence emission intensity to a two-
state model allowed us to obtain thermodynamic parameters compar-
able to those obtained by CD (ΔGH2O = 9.09±0.68 kcal mol−1, m =
1.81±0.13 kcal mol−1 M−1). However, in the case of BRD4(1), the
unfolding transition obtained by monitoring the fluorescence changes
could not be fitted to a two-state model because of a multiphasic profile
(Fig. 2B). This result can be explained by the observation that BRD4(1),
contrary to BRD2(2), contains more than one Trp residues, each mon-
itoring the conformational properties of different regions of the protein
(Fig. 1). Indeed, the different molecular environment of the fluor-
ophores in the two BRDs is also mirrored by the different fluorescence
emission spectra of their relative native states shown in Fig. S4.
Fig. 2. Urea-induced equilibrium unfolding of BRD2(2) and BRD4(1). (A) Normalized
molar ellipticity at 222 nm ([Θ]222) of BRD2(2) (circles) and BRD4(1) (squares) reported
after removal of the high-frequency noise and the low-frequency random error by SVD.
Continuous lines are the nonlinear regression to Eq. 2 of the data at different denaturant
concentrations, as described in Section 2. (B) Normalized relative intrinsic fluorescence
changes of BRD2(2) (circles) and BRD4(1) (squares). Continuous lines are the nonlinear
regression of the data at different denaturant concentrations fitted according to Eq. 2 for
BRD2(2), as described in Section 2. The dotted line interpolating the relative fluorescence
intensity for BRD4(1) (squares) is drawn as a guide to the eye. The reversibility points
(empty symbols) were not included in the nonlinear regression analysis.
Table 1
Thermodynamic parameters for urea-induced unfolding equilibrium of BRD2 (2) and
BRD4 (1) measured by far-UV CD and fluorescence spectroscopy.
BRD2(2) BRD4(1)
CD ([Θ]222) Fluorescence CD ([Θ]222)
ΔGH2 ° (kcal/mol) 8.83± 0.59 9.09± 0.68 11.52± 0.65
m (kcal/mol/M) 1.93± 0.13 1.81± 0.13 1.67±0.09
[Urea]0.5 (M) 4.57 5.02 6.90
Urea-induced unfolding equilibrium data were obtained as described in Materials and
methods. Data are reported as the mean±SE of the fit. For BRD4(1) fluorescence changes
could not be fitted to a two-state model because of a multiphasic profile (Fig. 2 B).
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3.2. Kinetic folding-unfolding experiments
To gain information on the folding mechanism of these two BRDs,
we carried out kinetic folding experiments at pH 7.5, 20 °C by fluor-
escence-monitored SF and T-jump experiments. The unfolding time
courses obtained by rapid-mixing SF experiments for BRD2(2) and
BRD4(1) were satisfactorily fitted to a single exponential decay at any
final denaturant concentration (see Fig. S5A and S5B for representative
unfolding time courses), while the refolding reaction was characterized
by two processes having relaxation constants in different time regime
(at [urea] around 1 M, k1 ~100 s-1 and k2 ~1 s-1) (see Fig. S5C and S5D
for representative refolding time courses). Since the slower refolding
phase is characterized by a smaller amplitude (less than 10% of the
faster phase) and is largely independent on denaturant concentration, it
probably originates from cis-trans proline isomerization, as often ob-
served in the folding of other proteins [21]
Fig. 3 shows the semi-logarithmic plot of the observed folding/un-
folding rate constants (excluding the slow proline isomerization folding
phase) versus denaturant concentration (chevron plot) obtained for
BRD2(2) (Fig. 3A) and BRD4(1) (Fig. 3B) from SF (closed symbols) and
T-jump (open symbols) experiments (see below). It should be noticed
that, whereas the logarithm of the observed unfolding rate constant
increases linearly with increasing denaturant concentration, both BRDs
show a deviation from linearity of the observed refolding rate constants
obtained by SF at low urea concentrations (roll-over effect). This non-
linear dependence of the folding rate constants evidenced in chevron
plots is generally interpreted as reflecting the accumulation of a folding
intermediate [19,22], even if different explanations have been pro-
posed and discussed [23].
We therefore hypothesized that an additional, and even faster
folding phase undetectable by SF experiments because of the dead time
of the mixing apparatus (2–3 ms), was to be observed under refolding
conditions in the sub-ms time regime. Indeed, this hypothesis was ex-
perimentally confirmed by T-jump folding experiments carried out
under matching temperature conditions (T = 20 °C) at different urea
concentrations. The time courses obtained under folding and unfolding
conditions were always satisfactorily fitted to a single exponential
decay at any denaturant concentration (representative kinetic traces are
reported in Fig. S6). The results of these experiments allowed us to
measure not only the rate constant relative to the rapid formation of the
intermediate, but also the kinetics of its unfolding at higher urea con-
centration. The data reported in Fig. 3 therefore represent the urea
dependence of the main folding phases for BRD2(2) (panel A) and
BRD4(1) (panel B): both proteins show a slower process observed by SF
experiments and relative to the (un)folding of the native state, and a
faster process, observed only by T-jump experiments, describing the
rapid folding and unfolding of an intermediate species. However, as
thoroughly discussed [19], identification of a transient folding inter-
mediate is not sufficient to assign its kinetic role in a three state me-
chanism. In particular, an intermediate state may represent an ob-
ligatory species toward the formation of the native state ( ⇌ ⇌D I N;
on-pathway intermediate), or a kinetic trap along the folding pathway
( ⇌ ⇌I D N; off-pathway intermediate). A clear distinction between
these two alternative scenarios can be obtained if the urea dependence
of all the four rate constants relative to the (un)folding of the native and
intermediate species (kDI, kID, kIN and kNI) are measured over a wide
range of urea concentration. Following an approach generally used to
analyze the folding mechanism of different proteins [13,19,24,25] we
globally fitted the SF and T-jump data reported in the chevron plots to a
three-state scheme, involving either an on- and an off-pathway inter-
mediate (Fig. 3A/B). The four microscopic rate constants and the cor-
responding m-values obtained by this procedure allowed us to assign to
the folding intermediate of BRD2(2) and BRD4(1) the role of an on-
pathway species along the pathway of folding to the native state, since
the off-pathway model fails to adequately fit the data in both cases. It is
interesting to notice that an obligatory transient folding intermediate
has been described also for the folding mechanism of other, non-re-
lated, four helical bundle proteins [13–15,26].
3.3. BRDs folding mechanism
Using the parameters obtained by the fit to the on-pathway model
(see legend to Fig. 3), we also determined the populations of the three
species at equilibrium as a function of urea concentration. Such an
analysis, predicts that the intermediate species identified in the folding
mechanism of both BRD domains is only negligible populated at equi-
librium (<1%) at urea concentration corresponding to the midpoint of
the folding transition (e.g. [urea] = 5.2 M and 6.4 M for BRD2(2) and
BRD4(1), respectively) (data not shown). The kinetic parameters ob-
tained from the on-pathway model were also used to calculate the en-
ergy profiles, highlighting the position of the intermediate and transi-
tion states along a reaction coordinate. As shown in Fig. 4, both BRDs
Fig. 3. Semilogarithmic plot (chevron plot) of the observed folding and unfolding rate
constants as a function of urea concentration by SF (closed symbols) and T-jump (open
symbols) experiments for BRD2(2) (panel A) and BRD4(1) (panel B). In panel A, the lines
are the best fit to a three-state model involving on- (continuous line) or off-pathway
(dashed line) intermediates [19]. BRD2(2) (Panel A): the calculated parameters for the
on-pathway model are are: kDI = 2357±831; mDI = 0.60±0.33; kID = 329±163; mID
= 0.16± 0.06; kIN = 570±211; mIN = 0.58± 0.34; kNI = 0.00010±0.00008; mNI =
0.53± 0.07. BRD4(1) (Panel B): the calculated parameters for the on-pathway model
(continuous line) are are: kDI = 924±130; mDI = 0.47± 0.02; kID = 0.007±0.010;
mID = 1.12±0.15; kIN = 875±115; mIN = 0.12± 0.02; kNI = 0.001±0.001; mNI =
0.40± 0.08. Rate constants are in s-1 and the associated m values are in kcal mol-1 M-1. In
the case of BRD4(1) the fit to an off-pathway model does not converge.
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fold along a minimal three-state mechanism involving a denatured-like
and a native-like transition states (TS1 and TS2, respectively), and on-
pathway intermediate in between. The calculated Tanford β-values (βT)
for TS1, reflecting the buried surface area relative to the unfolded and
native states, is βT = 0.32 for BRD2(2) and βT = 0.22 for BRD4(1),
whereas the βT for TS2 is 0.71 for BRD2(2) and 0.81 for BRD4(1). These
results suggest that the two transition states of the two proteins display
similar structural properties. On the contrary, the thermodynamic and
conformational properties of the intermediate species appear to be
largely different in the two BRDs; in fact, the intermediate populated by
BRD4(1) is more stable relative to that of BRD2(2) (ΔΔGDI =
5.7±0.8 kcal mol-1) and is clearly more native-like, as judged by its βT
value relative to the βT value calculated for BRD2(2) (βT = 0.7 and βT
= 0.4, respectively). The larger stability of the BRD4(1) intermediate
relative to that of the BRD2(2) mirrors the greater stability of its native
state (ΔΔGDN = 4.3±1.3 kcal mol-1 from kinetic data), suggesting that
this intermediate is stabilized by native-like interactions. Moreover,
inspection of Fig. 4 shows that the stabilities of the two transition states
TS1 and TS2 and the intermediate in between in the folding pathway
are correlated, as has been observed analyzing different sets of struc-
turally unrelated proteins following a three-state folding mechanism
[19,27]. Altogether, these observations suggest that formation of an
intermediate species is a common property of the folding of these two
BRDs; nevertheless, specific sequence features appear to be crucial to
modulate its stability and conformational properties.
Together with native state topology, inherent propensity to form
secondary structural elements is a key factor in modulating the folding
process of proteins [28] and its contribution can be clearly evidenced
studying the folding mechanism of homologous proteins sharing the
same topological properties. In particular, it has been shown that, as the
propensity for forming secondary structure increases, the folding me-
chanism of proteins of the same fold family slides from two-state to
multi-state mechanisms [29,30]. In the case of BRD2(2) and BRD4(1), a
comparison of helical propensities of sequence elements is meaningful,
given the high structural homology between these two proteins. Fig. 5
shows that the distribution of helical propensity (as calculated by
AGADIR [31],) between the two BRDs is very similar but that the
overall helical propensity is higher in the case of BRD4(1), particularly
at the level of the αC C-terminal helix. Phi-value analysis is in progress
and it will allow us to describe the structure of the intermediate and
transition states at the residue level and to check whether the C-term-
inal α−helix is part of the folding nucleus in these two BRDs.
4. Conclusions
A fruitful strategy for extracting general rules governing the folding
of proteins is the comparison of the folding mechanism of proteins
belonging to the same structural family. In this context, the bromodo-
mains (BRDs) offer an as yet unexplored experimental system to study
the folding mechanism of proteins belonging to the all-α fold class. In
this paper we have reported the thermodynamic characterization at
equilibrium and the folding kinetics of BRD2(2) and BRD4(1), two re-
presentative domains of domain 1 and 2 of the BET BRD family. The
results reported in this work allow us to propose that formation of an
obligatory intermediate may be a general feature of the folding land-
scape explored by these small all-α domains and add general sig-
nificance to the hypothesis that members of a given fold family share a
consensus folding mechanism. Our observations, however, highlight
that the intermediate species populated during the folding of BRD4(1)
is closer to the native state along the reaction coordinate than that
populated by the less stable BRD2(2). This conclusion, which will be
corroborated by structural analysis of folding intermediate(s) and
transition states, underscores the role played by the sequence in mod-
ulating the stability of transiently populated states.
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Fig. 4. Schematic energy diagrams for the folding of BRD2(2) (continuous line) and
BRD4(1) (dashed line). The free energy values and the βT values, were calculated from the
kinetic parameters obtained by fitting the chevron plots of the two BRD domains to an on
pathway intermediate (see the legend to Fig. 3). Free energy values were calculated with
the Arrhenius equation using a pre-exponential factor of 4.8 × 108 s-1 [15]. BRD2(2):
ΔGDI = 1.14 kcal mol-1; ΔGDN = 10.16 kcal mol-1; βT(TS1) = 0.32; βT(I) = 0.40; βT(TS2)
= 0.71. BRD4(1): ΔGDI = 6.83 kcal mol-1; ΔGDN = 14.80 kcal mol-1; βT(TS1) = 0.22;
βT(I) = 0.75; βT(TS2) = 0.80.
Fig. 5. Helical propensity of BRD2(2) (black line) and BRD4(1) (grey line). Helical pro-
pensity was calculated by the AGADIR program [31] (http://agadir.crg.es) Boxes re-
present the four helices, as determined from the X-ray structure of BRD2(2) (pdb id: 3oni;
black boxes) and BRD4(1) (pdb id: 3uvx; grey boxes).
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